Dr. Bharara Performs DRG Trial Using Proclaim™ DRG Neurostimulation System

Congrats to Dr. Niteesh Bharara on completing his first Dorsal Root Ganglion [DRG] stimulation trial! The Proclaim™ DRG Neurostimulation System is a new, non-opioid treatment specifically designed to help manage chronic nerve pain due to causalgia or CRPS following surgery or injury. DRG therapy may be able to provide you relief if you experience these symptoms in any of the following areas: foot, ankle, knee, groin or residual lower limb.

Proclaim™ DRG Neurostimulation System

To help people with chronic pain finally find relief and live healthier, fuller lives, Abbott launched the Proclaim™ DRG Neurostimulation System. This DRG stimulation therapy involves surgically placing a stimulator that targets the dorsal root ganglion to relieve pain of the lower limbs due to CRPS. Individuals have a hand-held iPod controller that changes the stimulation settings within prescribed limits.

This new technology has made a significant difference in the treatment of chronic pain. The 2017 Pain study found that people with chronic pain in a lower limb from CRPS experienced superior pain relief after 12 months with DRG stimulation. The numbers speak for themselves:

• 74.2 percent of people experienced meaningful pain relief with DRG stimulation, compared to 53 percent who received traditional spinal cord stimulation.
• One-third had more than 80 percent pain relief and no tingling sensation, which is a common side effect with traditional spinal cord stimulation.
• DRG stimulation led to a better quality of life compared to traditional spinal cord stimulation.

Abbott is a leader in healthcare technology and chronic pain treatment. With innovative devices like the Proclaim DRG Neurostimulation System, living with pain doesn’t have to sidetrack your life. To learn more about the Proclaim™ DRG Neurostimulation System, visit Abbott’s website.